Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

TP-10 phase I/II study results presented at cardiovascular anesthesiology meeting

May 15, 2000

Chloride channel blockers as novel therapeutic approach to sickle cell disease and other disorders

May 15, 2000

Medinox and Fuso to collaborate on development of new NO-neutralizing drug

May 12, 2000

Actelion announces results from phase III trial in pulmonary hypertension

May 12, 2000

Endovasc obtains funding to advance preclinical testing of NRA

May 12, 2000

Angiotensin II inhibition reduces early atherogenesis in monkeys

May 8, 2000

Approval of new indications for ACE inhibitor recommended by FDA advisory panel

May 4, 2000

Pfizer's new CETP inhibitors claimed for atherosclerosis and associated conditions

May 4, 2000

Sleep apnea linked to increased risk of hypertension

May 3, 2000

Trial demonstrates superior efficacy of amiodarone in treating atrial fibrillation

May 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...